<p><i><strong>Backed by a Strong Balance Sheet, MIRA Accelerates Toward Becoming a Clinical-Stage Company and Advancing Breakthroughs in Pain and Depression Treatment</strong></i></p>

Predicated on an unrivaled trove of millions of data points amassed over 20 years, these AI tools accurately predict near-term risk of ED, all-cause hospitalization, or death sans mitigation.

Trisha Pfluger, M.S., PMP, Chief Scientific Officer, and Nicholas Totagrande, CEO, Juno Biomedical, Inc. talk medical advancement, AI, and next steps for CELLTech™ DBS medical technology.

Newly Cleared Technology is a Game Changer for the Diagnosis of an Often Debilitating Disease

neurocare is pleased to announce that it has received FDA clearance for its industry-leading intermittent Theta Burst Stimulation (iTBS) protocol, available across its Apollo TMS Therapy System and other Transcranial Magnetic Stimulation systems for clinical practice.

Robert “Bob” Durkin to co-lead regulatory practice with partner Rend Al-Mondhiry

White Paper discussing patient improvements and potential mechanisms for patients with Long COVID.

The innovative new feature within the Parky app for Apple Watch is available by prescription for people with Parkinson’s disease.

The Food and Drug Administration approves CAR T-Cell therapy Carvykti® as a second-line treatment and the CAR T-Cell therapy Abecma® as a third-line treatment for adult patients with multiple myeloma.

Long-standing reputation for robust quality is confirmed as company enters 2024

FDA Grants CorDx Emergency Use Authorization for Multi-Target Rapid Test for Flu A/B & COVID-19

DropSafe® Sicura™ is the first and only fully passive safety needle in North America. Sicura™ designed to eliminate needlestick injuries, providing a safe injection experience, and is distributed by HTL-Strefa Inc., an MTD company.

DropSafe® Sicura™ is the first and only fully passive safety needle in North America. Sicura™ is designed to eliminate needlestick injuries, providing a safe injection experience, and is distributed by HTL-Strefa Inc., an MTD company.

Workshop Presented Overwhelming Scientific Evidence to Support CSF-HS as a Primary Biomarker in Neuropathic MPS Disorders

Agency’s decision signifies that ZetrOZ’s sustained acoustic medicine technology is safe and effective for promoting injury healing in wider range of medical conditions.

Independence Premium Foods Announces Ownership of Former Pet Food Production Facility

LCTG-001 on course to be the first FDA-approved biologic from human milk

Vapor Trade Group Warns Against What It Says Is FDA Misinformation That Jeopardizes Harm Reduction Mission

ForCast Orthopedics Receives Qualified Infection Disease Product (QIDP) Designation from FDA for the Treatment of Periprosthetic Joint Infection (PJI)

Approval gives way to the most comprehensive single menu offered by an AST platform while delivering precise, rapid results in 5.5 hours from isolated colonies.

ForCast Orthopedics Receives Qualified Infection Disease Product (QIDP) Designation from FDA for the Treatment of Periprosthetic Joint Infection (PJI)

In vitro antimicrobial resistance test enables clinical labs to deliver targeted therapeutic results days faster than the current standard of care, clearing the path for personalized antibiotic therapies

Leading Vapor Trade Group Urges FDA to Adopt Reforms to Protect Sanctity of Scientific Process

The funding, led by existing investors BioAdvance and Wellness Coaches, follows additional 3rd party studies by University College London and LateralDx, confirming that Senzo's Amplified Lateral Flow (ALF) platform returned greater than 98% accuracy against PCR, including in low viral-load samples

Endomag reaches a major milestone in its mission to deliver the best standard of breast cancer care for women around the world, with latest FDA approval.

Report Shows Banning Sale of Flavored Vape Products Would Have Adverse Effect on U.S. Economy and California

Director of the FDA Office of Cosmetics and Colors Speaks to the Association's Board

Vape Trade Group Warns That Latest FDA Action Risks Jeopardizing Agency Credibility and Harm Reduction Mission

Urges Agency to Pursue Ban While Preserving Market for Properly Regulated Vaping Products

Integrated QC dashboard and unlimited validation cycles for interim and final datasets creates industry's most user-friendly validator

Leading Trade Association Critical of Decision That Will Lead to Increase in Smoking

Naso Spray Voluntary Recall Lot 2373/21222

Recardio Inc., a late stage clinical-stage life science company developing regenerative therapies for cardiovascular diseases, announced that the FDA concurs with Recardio's pivotal Heal-MI Phase 3 trial design with Dutogliptin in Acute Myocardial Infarction.